ZyVersa Therapeutics
Stock Forecast, Prediction & Price Target
ZyVersa Therapeutics Financial Estimates
ZyVersa Therapeutics Revenue Estimates
ZyVersa Therapeutics EBITDA Estimates
ZyVersa Therapeutics Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $35M Low: $35M High: $35M avg. 0% |
Net Income
% change YoY
| $-8.90M N/A | $-759.09M -8423.89% | $-98.29M 87.05% | Avg: $-28.14M Low: $-4.50M High: $-468.01K avg. 71.36% | Avg: $-39.59M Low: $-6.41M High: $-380.26K avg. -40.67% | Avg: $-8.67M Low: $-8.67M High: $-8.67M avg. 78.08% | Avg: $-10.90M Low: $-10.90M High: $-10.90M avg. -25.61% |
EBITDA
% change YoY
| $-7.69M N/A | $-13.00M -69.00% | $-107.74M -728.59% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$19.13 N/A | -$2,925.42 -15192.31% | -$1,089.67 62.75% | Avg: -$25.5 Low: -$46.2 High: -$4.8 avg. 97.65% | Avg: -$34.85 Low: -$65.8 High: -$3.9 avg. -36.66% | Avg: -$89 Low: -$89 High: -$89 avg. -155.38% | Avg: -$111.8 Low: -$111.8 High: -$111.8 avg. -25.61% |
Operating Expenses
% change YoY
| $7.70M N/A | $13.01M 68.90% | $14.41M 10.73% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is ZyVersa Therapeutics stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 20.78% in 2025-2028.
We have gathered data from 1 analysts. Their low estimate is -4.50M, average is -28.14M and high is -468.01K.
What is ZyVersa Therapeutics stock revenue growth forecast?
We have gathered data from 2 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is ZyVersa Therapeutics stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -30.00% in 2025-2028.
We have gathered data from 1 analysts. Their low earnings per share estimate is -$46.2, average is -$25.5 and high is $-4.8.